「first」の検索結果
26件:11~15件目を表示
-

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical
ups. Notable among these is our leading line of Mytear artificial tear-type eye drops, Japan's first such product and one of the most respected brands in the OTC field. We have also devoted our e...
https://www.senju.co.jp/english/about/business/otc.html -

einafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, an ingredient that relieves hyperemia and...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -

Ethical Products for Medical Professionals | Business Activities | About Senju | SENJU Pharmaceutical
r the sensory organs that make possible the senses of sight, hearing, smell, taste, and touch. As a first step in pursuing this new avenue of opportunity, Senju Pharmaceutical has entered the promisin...
https://www.senju.co.jp/english/about/business/mp.html -

einafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, an ingredient that relieves hyperemia and...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -

产品开发方针 | 研究与开发 | 千寿制药株式会社
,其中超过10亿人尚未得到必要的治疗。报告还指出,导致全球视觉障碍或失明的主要原因包括 白内障、屈光不正(近视,老视等)、年龄相关性黄斑变性、青光眼、糖尿病视网膜病变等。 为创造针对眼部疾病的高价值(First in Class、Best in Class、 提升患者便利性等)产品,我们将继续全力推进研究开发活动。在产品战略上,我们将“为导致视觉障碍或者失明的眼部疾病做出贡献” 、“满足未满足的医...
http://www.senju.co.jp/chinese/rd/policy/